The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pathogenic variants in PTEN to predict for increased risk of relapse and death in patients with limited stage small cell bladder cancer.
 
Earle Frederick Burgess
Leadership - Johnson & Johnson
Stock and Other Ownership Interests - Becton Dickinson; Calithera Biosciences; Clovis Oncology; Exelixis; Gilead Sciences; Medtronic
Consulting or Advisory Role - Exelixis; Janssen; Takeda
Speakers' Bureau - Exelixis; Janssen; Roche/Genentech
Research Funding - Astellas Pharma; Pfizer
Travel, Accommodations, Expenses - Exelixis; Roche/Genentech
 
Nury Steuerwald
No Relationships to Disclose
 
James Thomas Symanowski
Consulting or Advisory Role - Boston Biomedical; CARsgen Therapeutics; Endocyte (Inst); Five Prime Therapeutics; Immatics; Lilly
 
Chad Livasy
No Relationships to Disclose
 
Carol J. Farhangfar
No Relationships to Disclose
 
Zoran Gatalica
Employment - Caris Life Sciences
 
David Arguello
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
 
Jason Zhu
Consulting or Advisory Role - Bayer; NGM Biopharmaceuticals
Travel, Accommodations, Expenses - UroToday
 
Claud Grigg
Consulting or Advisory Role - Pfizer/EMD Serono; Tempus
Travel, Accommodations, Expenses - Calithera Biosciences; Pfizer
 
Peter E. Clark
Research Funding - Galil Medical
 
Derek Raghavan
Consulting or Advisory Role - Caris Life Sciences (Inst); Gerson Lehrman Group